Akèy › Kansè ovè › Oklahoma › Tulsa
Etid klinik pou Kansè ovè nan Tulsa, OK
4 etid pou Kansè ovè ap chèche patisipan nan sit nan ak bò kote Tulsa (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
Ap rekriteFaz 3
- Oklahoma Cancer Specialists and Research Institute, LLC ( Site 0007), Tulsa
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
Ap rekriteFaz 3
- Oklahoma Cancer Specialists and Research Institute, LLC ( Site 0056), Tulsa
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Ap rekriteFaz 2/3
- Oklahoma Cancer Specialists and Research Institute, Tulsa
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Ap rekriteEtid obsèvasyon
- Massive Bio SYNERGY-AI site, Tulsa
Etid Kansè ovè nan lòt vil
- Houston, TX89 etid
- New York City, NY69 etid
- Boston, MA61 etid
- Los Angeles, CA50 etid
- Nashville, TN49 etid
- Arlington, VA46 etid
- Philadelphia, PA44 etid
- Columbus, OH39 etid
- St. Louis, MO38 etid
- Chicago, IL36 etid
- San Antonio, TX31 etid
- Cleveland, OH30 etid
Lòt etid nan Tulsa
- Ensifizyans kadyak10 etid
- Sipwa6 etid
- Obèsite5 etid
- Melanom5 etid
- Akidan serebral iskemi5 etid
- BPCO4 etid
- Maladi Parkinson4 etid
- Stenoz valv aòt4 etid
- Kansè kol4 etid
- Kansè nan tete4 etid
- Kansè Poumon ki pa ti selil4 etid
- Depresyon4 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.